Trust Co. of Vermont Boosts Stake in Colgate-Palmolive Company $CL

Trust Co. of Vermont boosted its holdings in Colgate-Palmolive Company (NYSE:CL) by 3.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,345 shares of the company’s stock after acquiring an additional 725 shares during the quarter. Trust Co. of Vermont’s holdings in Colgate-Palmolive were worth $1,940,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Westend Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 140 shares during the period. Cornerstone Planning Group LLC lifted its position in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after acquiring an additional 287 shares during the period. Saudi Central Bank purchased a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $29,000. Ransom Advisory Ltd purchased a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $37,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 1.2%

Shares of NYSE CL opened at $78.95 on Thursday. The firm has a market cap of $63.81 billion, a P/E ratio of 22.18, a price-to-earnings-growth ratio of 4.16 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a 1 year low of $78.76 and a 1 year high of $102.61. The firm’s 50 day moving average price is $83.69 and its 200 day moving average price is $88.50.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm posted $0.91 EPS. Colgate-Palmolive’s revenue was up 1.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. UBS Group lowered their target price on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Barclays lowered their price objective on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Citigroup lowered their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday, August 4th. Finally, JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $97.27.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.